| Employment |
| No Relationships to Disclose |
|
|
| Leadership |
| No Relationships to Disclose |
|
|
| Stock and Other Ownership Interests |
| No Relationships to Disclose |
|
|
| Honoraria |
| No Relationships to Disclose |
|
|
| Consulting or Advisory Role |
| Company: Genentech |
| Recipient: You |
| Company: Lilly |
| Recipient: You |
| Company: Celgene |
| Recipient: You |
| Company: Merck |
| Recipient: You |
| Company: Astra Zeneca |
| Recipient: You |
| Company: Blueprint Genetics |
| Recipient: You |
| Company: Shionogi |
| Recipient: You |
| Company: Daiichi Sankyo/Astra Zeneca |
| Recipient: You |
| Company: Regeneron/ Sanofi |
| Recipient: You |
| Company: Eisai |
| Recipient: You |
| Company: BeiGene |
| Recipient: You |
| Company: Turning Point Therapeutics |
| Recipient: You |
| Company: Pfizer |
| Recipient: You |
| Company: Janssen |
| Recipient: You |
| Company: Boehringer Ingelheim |
| Recipient: You |
|
| Speakers' Bureau |
| Company: AstraZeneca |
| Recipient: An Immediate Family Member |
| Company: Roche/Genentech |
| Recipient: An Immediate Family Member |
|
| Research Funding |
| Company: Genentech/Roche |
| Recipient: Your Institution |
| Company: Incyte |
| Recipient: Your Institution |
| Company: Macrogenics |
| Recipient: Your Institution |
| Company: Merck Sharp & Dohme |
| Recipient: Your Institution |
| Company: AstraZeneca/MedImmune |
| Recipient: Your Institution |
|
| Patents, Royalties, Other Intellectual Property |
| No Relationships to Disclose |
|
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| No Relationships to Disclose |
|
|
| Other Relationship |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Uncompensated Relationships |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Open Payments Link |
| No Relationships to Disclose |
|
|